DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers

Phase 1

Completed

Conditions: Tuberculosis

Interventions: Biological: BCG Danish

First Posted Date: 2021-03-02

Last Posted Date: 2025-02-06

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT04777721

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Computer Assisted Lessening of Intrusive Memories in the Emergency Department

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Behavioral: Simple cognitive task

First Posted Date: 2021-02-25

Last Posted Date: 2021-02-25

Lead Sponsor: University of Oxford

Target Recruit Count: 14

Registration Number: NCT04769999

Locations: 🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
🇬🇧
Royal Berkshire NHS Foundation Trust, Reading, United Kingdom
🇬🇧
South Central Ambulance Service NHS Foundation Trust, Bicester, United Kingdom

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Early Phase 1

Completed

Conditions: Rift Valley Fever

Interventions: Biological: ChAdOx1 RVF

First Posted Date: 2021-02-15

Last Posted Date: 2023-05-19

Lead Sponsor: University of Oxford

Target Recruit Count: 15

Registration Number: NCT04754776

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Rational Use of Personal Protective Equipment During COVID-19 Pandemic

Not Applicable

Completed

Conditions: Personal Protective Equipment
Covid19

Interventions: Other: New PPE
Other: Old PPE

First Posted Date: 2021-01-15

Last Posted Date: 2021-01-15

Lead Sponsor: University of Oxford

Target Recruit Count: 67

Registration Number: NCT04712045

Locations: 🇬🇧
Professor Peter McCulloch, Oxford, Oxfordshire, United Kingdom

Southeast Asia Dose Optimization of Tafenoquine

Phase 4

Recruiting

Conditions: Plasmodium Vivax Malaria

Interventions: Drug: Tafenoquine
Drug: Chloroquine
Drug: Artemether 20 mg-Lumefantrine 120 mg

First Posted Date: 2021-01-12

Last Posted Date: 2025-03-06

Lead Sponsor: University of Oxford

Target Recruit Count: 700

Registration Number: NCT04704999

Locations: 🇱🇦
Lao Oxford Mahosot Hospital Wellcome Trust Research Unit (LOMWRU), Vientiane, Lao People's Democratic Republic
🇻🇳
Oxford University Clinical Research Unit (OUCRU), Binh Phuoc, Vietnam
🇰🇭
Mahidol Oxford Tropical Medicine Research Unit (MORU), Cambodia, Siem Reap, Cambodia

and more 2 locations

R21/Matrix-M in African Children Against Clinical Malaria

Phase 3

Active, not recruiting

Conditions: Malaria

Interventions: Biological: R21/Matrix-M
Biological: Rabies vaccine or Hepatitis A vaccine

First Posted Date: 2021-01-12

Last Posted Date: 2024-05-17

Lead Sponsor: University of Oxford

Target Recruit Count: 4800

Registration Number: NCT04704830

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Phase 1

Completed

Conditions: RVF
Rift Valley Fever

Interventions: Other: Saline
Biological: ChAdOx1 RVF

First Posted Date: 2020-12-17

Last Posted Date: 2023-02-06

Lead Sponsor: University of Oxford

Target Recruit Count: 30

Registration Number: NCT04672824

Locations: 🇺🇬
MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda

Saving Babies Lives

Not Applicable

Completed

Conditions: Perinatal Mortality

Interventions: Behavioral: No Saving Babies Lives Programme
Behavioral: Saving Babies Lives Programme

First Posted Date: 2020-12-11

Last Posted Date: 2024-03-12

Lead Sponsor: University of Oxford

Target Recruit Count: 24040

Registration Number: NCT04663620

Locations: 🇰🇭
Angkor Hospital for Children, Siem Reap, Cambodia

Online Culture for Mental Health in People Aged 16-24

Not Applicable

Completed

Conditions: Depression
Anxiety

Interventions: Other: WofB
Other: Ashmolean Website

First Posted Date: 2020-12-11

Last Posted Date: 2022-05-06

Lead Sponsor: University of Oxford

Target Recruit Count: 463

Registration Number: NCT04663594

Locations: 🇬🇧
Ashmolean Museum Website, Oxford, Oxfordshire, United Kingdom

7-day Simvastatin and Emotional Processing

Phase 1

Completed

Conditions: Inflammation
Depression

Interventions: Drug: Simvastatin 20mg
Drug: Placebo

First Posted Date: 2020-12-03

Last Posted Date: 2022-11-03

Lead Sponsor: University of Oxford

Target Recruit Count: 53

Registration Number: NCT04652089

Locations: 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy